More than 20 years ago, Congress created the 340B Drug Pricing Program to allow eligible hospitals and health systems to stretch limited resources and expand access to care for vulnerable patients. But despite a proven track record of increasing patient access to vital medical services and decreasing government spending, some want changes that would weaken the program.   

340B hospitals continue to help care for low-income and uninsured patients. That is why the AHA sponsored today’s Capitol Hill briefing at which hospitals leaders shared examples of how their 340B programs help their patients and communities. Participating hospitals included Temple University Hospital in Philadelphia; Saint Thomas Health part of Ascension Health in Nashville, Tenn.; Trinity Health in Livonia, Mich.; and Providence Health & Services in Seattle. 

At the briefing, legislators and their staff heard how hospitals use the savings they receive from discounts on high prescription drug prices to reinvest in programs that enhance patient services and access to care.  

They heard how hospitals use 340B savings to provide local access to drugs and treatments for cancer patients, clinical pharmacy services, community outreach programs, free vaccinations, transportation to patients for follow-up appointments and many other services to their communities.   

In August, the Health Resources and Services Administration – the federal agency responsible for administering the 340B program – proposed new policies for the 340 program. Taken together, the changes could jeopardize eligible hospitals’ ability to care for vulnerable patients and communities. 

At the same time, the pharmaceutical industry and its supporters continue to make unsubstantiated claims about the program to persuade Congress to scale it back significantly.  

Hospital leaders are concerned that scaling back the 340B program would force hospitals to curtail or even eliminate services that are essential to keeping patients and communities healthy. Congress should heed the concerns of providers on the front lines of care – and toss aside the arguments of those who wish only to add to the record profits of pharmaceutical companies.

Watch our new video on why the 340B program is so important. And check out all of our 340B resources at www.aha.org/protect340B

Related News Articles

Perspective
On Tuesday, the Census Bureau reported that “a third of Americans now show signs of clinical anxiety or depression” due to the COVID-19 pandemic. It’s also…
Headline
The Centers for Medicare & Medicaid Services yesterday released a fact sheet for state and local governments seeking Medicare, Medicaid or Children’s…
Headline
An annual report into death by several factors tied to mental health and wellbeing — otherwise referred to as “deaths of despair” — topped 150,000 in 2018. The…
Headline
State Medicaid programs are reporting an uptick in enrollment compared with their fiscal year 2020 projections, due in part to the COVID-19 pandemic. The…
Headline
As part of Mental Health Awareness Month, Bruce Bailey, president and CEO of Tidelands Health based in Georgetown, S.C., talks about how hospitals and health…
Blog
Like all of America’s hospitals, Tidelands Health has a longstanding commitment to improving access to high-quality, affordable services. This includes…